Form 4 for SONM DNA X, Inc.
Accepted 2025-02-10 00:00:00 ET · period of report 2025-02-06 · accession 0001493152-25-005764 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-10 | 2025-02-06 | SONM | Becher Charles | See Remarks | A - Grant | $0.00 | +70.7K | 94.0K | +303% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-06 | A | A | 70,671 | $0.00 | 93,994 | D | — | — | (F1) Represents the grant of restricted stock units that vest in two equal installments on the 90th and 180th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. (F3) The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9. (F2) Consists of (i) 23,323 shares of common stock and (ii) 70,671 unvested restricted stock units. |